OBJECTIVE: The objective of the study was to investigate the combined effects of three sets of regulatory factors: cell pre-differentiation, soluble factors and medium perfusion on spatial control of human mesenchymal stem cell (hMSC) differentiation into cells forming the cartilaginous and bone regions in engineered osteochondral constructs. DESIGN: Bone-marrow derived hMSCs were expanded in their undifferentiated state (UD) or pre-differentiated (PD) in monolayer culture, seeded into biphasic constructs by interfacing agarose gels and bone scaffolds and cultured for 5 weeks either statically (S) or in a bioreactor (BR) with perfusion of medium through the bone region. Each culture system was operated with medium containing either chondrogenic supplements (C) or a cocktail (Ck) of chondrogenic and osteogenic supplements. RESULTS: The formation of engineered cartilage in the gel region was most enhanced by using undifferentiated cells and chondrogenic medium, whereas the cartilaginous properties were negatively affected by using pre-differentiated cells or the combination of perfusion and cocktail medium. The formation of engineered bone in the porous scaffold region was most enhanced by using pre-differentiated cells, perfusion and cocktail medium. Perfusion also enhanced the integration of bone and cartilage regions. CONCLUSIONS: (1) Pre-differentiation of hMSCs before seeding on scaffold was beneficial for bone but not for cartilage formation. (2) The combination of medium perfusion and cocktail medium inhibited chondrogenesis of hMSCs. (3) Perfusion improved the cell and matrix distribution in the bone region and augmented the integration at the bone-cartilage interface. (4) Osteochondral grafts can be engineered by differentially regulating the culture conditions in the two regions of the scaffold seeded with hMSCs (hydrogel for cartilage, perfused porous scaffold for bone). Copyright 2010 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
OBJECTIVE: The objective of the study was to investigate the combined effects of three sets of regulatory factors: cell pre-differentiation, soluble factors and medium perfusion on spatial control of human mesenchymal stem cell (hMSC) differentiation into cells forming the cartilaginous and bone regions in engineered osteochondral constructs. DESIGN: Bone-marrow derived hMSCs were expanded in their undifferentiated state (UD) or pre-differentiated (PD) in monolayer culture, seeded into biphasic constructs by interfacing agarose gels and bone scaffolds and cultured for 5 weeks either statically (S) or in a bioreactor (BR) with perfusion of medium through the bone region. Each culture system was operated with medium containing either chondrogenic supplements (C) or a cocktail (Ck) of chondrogenic and osteogenic supplements. RESULTS: The formation of engineered cartilage in the gel region was most enhanced by using undifferentiated cells and chondrogenic medium, whereas the cartilaginous properties were negatively affected by using pre-differentiated cells or the combination of perfusion and cocktail medium. The formation of engineered bone in the porous scaffold region was most enhanced by using pre-differentiated cells, perfusion and cocktail medium. Perfusion also enhanced the integration of bone and cartilage regions. CONCLUSIONS: (1) Pre-differentiation of hMSCs before seeding on scaffold was beneficial for bone but not for cartilage formation. (2) The combination of medium perfusion and cocktail medium inhibited chondrogenesis of hMSCs. (3) Perfusion improved the cell and matrix distribution in the bone region and augmented the integration at the bone-cartilage interface. (4) Osteochondral grafts can be engineered by differentially regulating the culture conditions in the two regions of the scaffold seeded with hMSCs (hydrogel for cartilage, perfused porous scaffold for bone). Copyright 2010 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
Authors: Lorenz Meinel; Vassilis Karageorgiou; Robert Fajardo; Brian Snyder; Vivek Shinde-Patil; Ludwig Zichner; David Kaplan; Robert Langer; Gordana Vunjak-Novakovic Journal: Ann Biomed Eng Date: 2004-01 Impact factor: 3.934
Authors: R L Mauck; M A Soltz; C C Wang; D D Wong; P H Chao; W B Valhmu; C T Hung; G A Ateshian Journal: J Biomech Eng Date: 2000-06 Impact factor: 2.097
Authors: Eric G Lima; Robert L Mauck; Shelley H Han; Seonghun Park; Kenneth W Ng; Gerard A Ateshian; Clark T Hung Journal: Biorheology Date: 2004 Impact factor: 1.875
Authors: E G Lima; L Bian; K W Ng; R L Mauck; B A Byers; R S Tuan; G A Ateshian; C T Hung Journal: Osteoarthritis Cartilage Date: 2007-05-10 Impact factor: 6.576
Authors: Dirk Schaefer; Ivan Martin; G Jundt; Joachim Seidel; Michael Heberer; Alan Grodzinsky; Ingrid Bergin; Gordana Vunjak-Novakovic; Lisa E Freed Journal: Arthritis Rheum Date: 2002-09
Authors: Richard Tuli; Sumon Nandi; Wan-Ju Li; Suraj Tuli; Xiaoxue Huang; Paul A Manner; Patrice Laquerriere; Ulrich Nöth; David J Hall; Rocky S Tuan Journal: Tissue Eng Date: 2004 Jul-Aug
Authors: Adel Alhadlaq; Jennifer H Elisseeff; Liu Hong; Christopher G Williams; Arnold I Caplan; Blanka Sharma; Ross A Kopher; Sara Tomkoria; Donald P Lennon; Aurora Lopez; Jeremy J Mao Journal: Ann Biomed Eng Date: 2004-07 Impact factor: 3.934
Authors: Liliana F Mellor; Mahsa Mohiti-Asli; John Williams; Arthi Kannan; Morgan R Dent; Farshid Guilak; Elizabeth G Loboa Journal: Tissue Eng Part A Date: 2015-07-13 Impact factor: 3.845
Authors: Nguyen P T Huynh; Jonathan M Brunger; Catherine C Gloss; Franklin T Moutos; Charles A Gersbach; Farshid Guilak Journal: Tissue Eng Part A Date: 2018-07-13 Impact factor: 3.845